共 29 条
[1]
Exploitation of theselectivity-conferring code of nonribosomal peptide synthetases forthe rational design of peptide antibiotics. Eppelmann K,Stachelhaus T,Marhiel M A. Biochemistry . 2002
[2]
Ethyl-substitutederythromycin derivatives produced by directed metabolicengineering. Stassi D L,Kakavas S J,Reynolds K A,et al. Proceedings of the National Academy of Sciences of the United States of America . 1998
[3]
Nonribosomal peptides:from genes to products. Schwarzer D,Finking R,Marahiel M A. Natural Product Reports . 2003
[4]
Engineering broaderspecificity into an antibiotic-producing polyketide synthase. Marsden F A,Wilkinson B,Cortes J,et al. Science . 1998
[5]
微生物药物学[M]. 化学工业出版社 , 张致平主编, 2003
[6]
The specificity-conferring code of adenylation domains in nonribosomal peptidesyhthetases. Stachelhaus T,Mootz H D,Marahiel M A. Chemistry and Biology . 1999
[7]
Decreasing the ring size ofa cyclic nonribosomal peptide antibiotic by in-frame moduledeletion in the biosynthetic genes. Mootz H D,Kessler N,Linne U,et al. Journal of the American Chemical Society . 2002
[8]
Metabolic engineering for drug discoveryand development. Khosla C,Keasling J D. Nature Reviews Neuroscience . 2003
[9]
Multiplegenetic modifications of the erythromycm polyketide synthase toproduce a library of novel "unnatural" natural products. McDaniel R,Thamchaipenet A,Gustafsson C,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
[10]
Enediyne natural products: biosynthesis and prospect towards engineering novel antitumor agents. Shen B,Liu W,Nonaka K. Current Medicinal Chemistry . 2003